Future Trajectory and Innovation Potential. These barcoded molecules hybridize directly with the target sequences in fixed cells, tissues, or purified nucleic acids, maintaining the spatial context of the original sample.
Preserving Tissue Architecture Integrity with NanoString Technology
By leveraging proprietary barcoded probes, the platform captures specific RNA or protein targets directly within a sample, transforming complex biological information into quantifiable digital data. The technology also maintains the integrity of the tissue architecture, enabling correlation between molecular profiles and histological morphology.
Each probe is designed with a unique identifier, or barcode, that corresponds to a specific gene or protein target, allowing for massive multiplexing capabilities within a single assay. Regulatory approvals for specific nCounter assays have solidified its role in personalized medicine, where it guides therapeutic decisions by matching patients with the most effective treatment options based on their molecular profile.
Preserving Tissue Architecture Integrity with NanoString Technology
Preserving Sample Integrity and Context One of the most significant differentiators is the compatibility with formalin-fixed, paraffin-embedded (FFPE) samples, which are the standard in clinical pathology. The workflow bypasses reverse transcription and enzymatic amplification, significantly reducing hands-on time and minimizing the risk of amplification-induced artifacts.
More About What is nanostring
Looking at What is nanostring from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on What is nanostring can make the topic easier to follow by connecting earlier points with a few simple takeaways.
